The overlap between irritable bowel syndrome and organic gastrointestinal diseases
- PMID: 33189181
- DOI: 10.1016/S2468-1253(20)30212-0
The overlap between irritable bowel syndrome and organic gastrointestinal diseases
Abstract
Irritable bowel syndrome (IBS) is a common functional bowel disorder characterised by symptoms of recurrent abdominal pain associated with a change in bowel habit. This condition is one of the most frequent reasons to seek a gastroenterology consultation in primary and secondary care. The diagnosis of IBS is made by identifying characteristic symptoms, as defined by the Rome criteria, and excluding organic gastrointestinal diseases that might otherwise explain these symptoms. Organic conditions that can be mistaken for IBS include coeliac disease, inflammatory bowel disease (IBD), colorectal cancer, and, in those with diarrhoea-predominant symptoms, chronic gastrointestinal infections, microscopic colitis, and primary bile acid diarrhoea. The concept of small intestinal bacterial overgrowth being associated with IBS is shrouded with controversy and uncertainty, mainly because of invalid tests due to poor sensitivity and specificity, potentially leading to incorrect assumptions. There is insufficient evidence to link IBS-type symptoms with exocrine pancreatic insufficiency or with symptomatic uncomplicated diverticular disease, since both are hampered by conflicting data. Finally, there is growing appreciation that IBS can present in patients with known but stable organic gastrointestinal diseases, such as quiescent IBD or coeliac disease. Recognising functional gut symptoms in these individuals is paramount so that potentially harmful escalations in immunosuppressive therapy can be avoided and attention can be focused on addressing disorders of gut-brain interaction. This Review endeavours to aid clinicians who practise adult gastroenterology in recognising the potential overlap between IBS and organic gastrointestinal diseases and highlights areas in need of further research and clarity.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
The prevalence of coeliac disease in patients fulfilling Rome III criteria for irritable bowel syndrome.Arab J Gastroenterol. 2016 Jun;17(2):73-7. doi: 10.1016/j.ajg.2016.05.003. Epub 2016 Jun 24. Arab J Gastroenterol. 2016. PMID: 27349575
-
Prodromal irritable bowel syndrome may be responsible for delays in diagnosis in patients presenting with unrecognized Crohn's disease and celiac disease, but not ulcerative colitis.Dig Dis Sci. 2011 Nov;56(11):3270-5. doi: 10.1007/s10620-011-1783-y. Epub 2011 Jun 22. Dig Dis Sci. 2011. PMID: 21695401
-
Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study.Inflamm Bowel Dis. 2013 Mar;19(3):550-3. doi: 10.1097/MIB.0b013e31827febfd. Inflamm Bowel Dis. 2013. PMID: 23380937 Clinical Trial.
-
A systematic review and meta-analysis on the prevalence of non-malignant, organic gastrointestinal disorders misdiagnosed as irritable bowel syndrome.Sci Rep. 2022 Feb 4;12(1):1949. doi: 10.1038/s41598-022-05933-1. Sci Rep. 2022. PMID: 35121775 Free PMC article.
-
Review article: Diagnosis and investigation of irritable bowel syndrome.Aliment Pharmacol Ther. 2021 Dec;54 Suppl 1:S33-S43. doi: 10.1111/apt.16597. Aliment Pharmacol Ther. 2021. PMID: 34927756 Review.
Cited by
-
Electroacupuncture Improving Intestinal Barrier Function in Rats with Irritable Bowel Syndrome Through Regulating Aquaporins.Dig Dis Sci. 2024 Apr;69(4):1143-1155. doi: 10.1007/s10620-024-08288-x. Epub 2024 Feb 29. Dig Dis Sci. 2024. PMID: 38421507
-
The Causal Association of Irritable Bowel Syndrome with Multiple Disease Outcomes: A Phenome-Wide Mendelian Randomization Study.J Clin Med. 2023 Jan 31;12(3):1106. doi: 10.3390/jcm12031106. J Clin Med. 2023. PMID: 36769754 Free PMC article.
-
The Potential Role of Human Milk Oligosaccharides in Irritable Bowel Syndrome.Microorganisms. 2022 Nov 25;10(12):2338. doi: 10.3390/microorganisms10122338. Microorganisms. 2022. PMID: 36557589 Free PMC article. Review.
-
Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases.Front Microbiol. 2021 Aug 9;12:689958. doi: 10.3389/fmicb.2021.689958. eCollection 2021. Front Microbiol. 2021. PMID: 34434175 Free PMC article. Review.
-
Public Awareness of Bowel Cancer Risk Factors, Symptoms and Screening in Tasmania, Australia: A Cross-Sectional Study.Int J Environ Res Public Health. 2022 Jan 28;19(3):1497. doi: 10.3390/ijerph19031497. Int J Environ Res Public Health. 2022. PMID: 35162541 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical